BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34212902)

  • 21. Relationship among serum pepsinogens, serum gastrin, gastric mucosal histology and H. pylori virulence factors in a paediatric population.
    Lopes AI; Palha A; Lopes T; Monteiro L; Oleastro M; Fernandes A
    Scand J Gastroenterol; 2006 May; 41(5):524-31. PubMed ID: 16638693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypergastrinemia in Long-Term Use of Proton Pump Inhibitors.
    Shiotani A; Katsumata R; Gouda K; Fukushima S; Nakato R; Murao T; Ishii M; Fujita M; Matsumoto H; Sakakibara T
    Digestion; 2018; 97(2):154-162. PubMed ID: 29310112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran.
    Nejadi-Kelarijani F; Roshandel G; Semnani S; Ahmadi A; Faghani B; Besharat S; Akhavan-Tabib A; Amiriani T
    Asian Pac J Cancer Prev; 2014; 15(17):7433-6. PubMed ID: 25227854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric acid secretion, serum pepsinogen I, and serum gastrin in Japanese with gastric hyperplastic polyps or polypoid-type early gastric carcinoma.
    Haruma K; Yoshihara M; Sumii K; Tari A; Watanabe C; Kodoi A; Kajiyama G
    Scand J Gastroenterol; 1993 Jul; 28(7):633-7. PubMed ID: 8362219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of omeprazole treatment on plasma concentrations of the gastric peptides, xenin, gastrin and somatostatin, and of pepsinogen.
    Stoschus B; Hamscher G; Ikonomou S; Partoulas G; Eberle C; Sauerbruch T; Feurle GE
    J Pept Res; 1998 Jul; 52(1):27-33. PubMed ID: 9716248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. G- and D-cell populations, serum and tissue concentrations of gastrin and somatostatin in patients with peptic ulcer diseases.
    Park SM; Park HS
    Korean J Intern Med; 1993 Jan; 8(1):1-7. PubMed ID: 7903552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroepidemiology of gastritis in Japanese and Dutch male employees with and without ulcer disease.
    Schlemper RJ; van der Werf SD; Biemond I; Lamers CB
    Eur J Gastroenterol Hepatol; 1996 Jan; 8(1):33-9. PubMed ID: 8900906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The gastrin and pepsinogen levels of patients with chronic atrophic gastritis and duodenal ulcer].
    Valenkevich LN
    Lik Sprava; 1993; (2-3):56-9. PubMed ID: 8191737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Potentialities of a serological method in diagnosis of atrophic gastritis].
    Pimenov SI; Makarenko EV
    Ter Arkh; 2008; 80(2):15-21. PubMed ID: 18372589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter pylori, pepsinogens and gastrin: relationship with age and development of atrophic gastritis.
    Kuipers EJ; Pals G; Peña AS; van Uffelen CW; Kok A; Westerveld BD; Meuwissen SG
    Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):153-6. PubMed ID: 8723421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in the histology and function of gastric mucosa and in Helicobacter pylori colonization during a long-term follow-up period after vagotomy in duodenal ulcer patients.
    Peetsalu M; Valle J; Härkönen M; Maaroos HI; Peetsalu A
    Hepatogastroenterology; 2005; 52(63):785-91. PubMed ID: 15966205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastric vascular ectasias in cirrhosis: association with hypoacidity not related to gastric atrophy.
    Pérez-Ayuso RM; Piqué JM; Saperas E; Bombí JA; Bordas JM; Elena M; Navarro S; Terés J
    Scand J Gastroenterol; 1989 Nov; 24(9):1073-8. PubMed ID: 2595268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of RP 40749 on basal and meal-stimulated serum-gastrin, serum-pepsinogen I, and gastrin-content of the antral mucosa in duodenal ulcer patients.
    Nelis GF; Lamers CB; Pals G
    Dig Dis Sci; 1985 Jul; 30(7):617-23. PubMed ID: 4006644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
    Maconi G; Lazzaroni M; Sangaletti O; Bargiggia S; Vago L; Bianchi Porro G
    Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The serological gastric biopsy: a non-endoscopical diagnostic approach in management of the dyspeptic patient: significance for primary care based on a survey of the literature.
    Korstanje A; den Hartog G; Biemond I; Lamers CB
    Scand J Gastroenterol Suppl; 2002; (236):22-6. PubMed ID: 12408500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori.
    Schlemper RJ; van der Werf SD; Vandenbroucke JP; Biemond I; Lamers CB
    Gut; 1995 Aug; 37(2):199-204. PubMed ID: 7557568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histologic and serum risk markers for noncardia early gastric cancer.
    Shiotani A; Iishi H; Uedo N; Kumamoto M; Nakae Y; Ishiguro S; Tatsuta M; Graham DY
    Int J Cancer; 2005 Jun; 115(3):463-9. PubMed ID: 15688378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in gastrin and serum pepsinogens in monitoring of Helicobacter pylori response to therapy.
    Pérez-Paramo M; Albillos A; Calleja JL; Salas C; Marín MC; Marcos ML; Cacho G; Escartín P; Ortiz-Berrocal J
    Dig Dis Sci; 1997 Aug; 42(8):1734-40. PubMed ID: 9286242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum pepsinogen levels in gastric cancer patients and their relationship with Helicobacter pylori infection: a prospective study.
    So JB; Yeoh KG; Moochala S; Chachlani N; Ho J; Wong WK; Mack P; Goh PM
    Gastric Cancer; 2002; 5(4):228-32. PubMed ID: 12491081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia.
    Annibale B; Aprile MR; D'ambra G; Caruana P; Bordi C; Delle Fave G
    Aliment Pharmacol Ther; 2000 May; 14(5):625-34. PubMed ID: 10792127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.